scholarly journals A Novel Method for LncRNA-Disease Association Prediction Based on an lncRNA-Disease Association Network

Author(s):  
Pengyao Ping ◽  
Lei Wang ◽  
Linai Kuang ◽  
Songtao Ye ◽  
Muhammad Faisal Buland Iqbal ◽  
...  
2018 ◽  
Vol 2018 ◽  
pp. 1-11 ◽  
Author(s):  
Shunxian Zhou ◽  
Zhanwei Xuan ◽  
Lei Wang ◽  
Pengyao Ping ◽  
Tingrui Pei

Motivation. Increasing studies have demonstrated that many human complex diseases are associated with not only microRNAs, but also long-noncoding RNAs (lncRNAs). LncRNAs and microRNA play significant roles in various biological processes. Therefore, developing effective computational models for predicting novel associations between diseases and lncRNA-miRNA pairs (LMPairs) will be beneficial to not only the understanding of disease mechanisms at lncRNA-miRNA level and the detection of disease biomarkers for disease diagnosis, treatment, prognosis, and prevention, but also the understanding of interactions between diseases and LMPairs at disease level.Results. It is well known that genes with similar functions are often associated with similar diseases. In this article, a novel model named PADLMP for predicting associations between diseases and LMPairs is proposed. In this model, a Disease-LncRNA-miRNA (DLM) tripartite network was designed firstly by integrating the lncRNA-disease association network and miRNA-disease association network; then we constructed the disease-LMPairs bipartite association network based on the DLM network and lncRNA-miRNA association network; finally, we predicted potential associations between diseases and LMPairs based on the newly constructed disease-LMPair network. Simulation results show that PADLMP can achieve AUCs of 0.9318, 0.9090 ± 0.0264, and 0.8950 ± 0.0027 in the LOOCV, 2-fold, and 5-fold cross validation framework, respectively, which demonstrate the reliable prediction performance of PADLMP.


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Shanchen Pang ◽  
Yu Zhuang ◽  
Xinzeng Wang ◽  
Fuyu Wang ◽  
Sibo Qiao

Abstract Background A large number of biological studies have shown that miRNAs are inextricably linked to many complex diseases. Studying the miRNA-disease associations could provide us a root cause understanding of the underlying pathogenesis in which promotes the progress of drug development. However, traditional biological experiments are very time-consuming and costly. Therefore, we come up with an efficient models to solve this challenge. Results In this work, we propose a deep learning model called EOESGC to predict potential miRNA-disease associations based on embedding of embedding and simplified convolutional network. Firstly, integrated disease similarity, integrated miRNA similarity, and miRNA-disease association network are used to construct a coupled heterogeneous graph, and the edges with low similarity are removed to simplify the graph structure and ensure the effectiveness of edges. Secondly, the Embedding of embedding model (EOE) is used to learn edge information in the coupled heterogeneous graph. The training rule of the model is that the associated nodes are close to each other and the unassociated nodes are far away from each other. Based on this rule, edge information learned is added into node embedding as supplementary information to enrich node information. Then, node embedding of EOE model training as a new feature of miRNA and disease, and information aggregation is performed by simplified graph convolution model, in which each level of convolution can aggregate multi-hop neighbor information. In this step, we only use the miRNA-disease association network to further simplify the graph structure, thus reducing the computational complexity. Finally, feature embeddings of both miRNA and disease are spliced into the MLP for prediction. On the EOESGC evaluation part, the AUC, AUPR, and F1-score of our model are 0.9658, 0.8543 and 0.8644 by 5-fold cross-validation respectively. Compared with the latest published models, our model shows better results. In addition, we predict the top 20 potential miRNAs for breast cancer and lung cancer, most of which are validated in the dbDEMC and HMDD3.2 databases. Conclusion The comprehensive experimental results show that EOESGC can effectively identify the potential miRNA-disease associations.


RSC Advances ◽  
2017 ◽  
Vol 7 (51) ◽  
pp. 32216-32224 ◽  
Author(s):  
Xiaoying Li ◽  
Yaping Lin ◽  
Changlong Gu

The NSIM integrates the disease similarity network, miRNA similarity network, and known miRNA-disease association network on the basis of cousin similarity to predict not only novel miRNA-disease associations but also isolated diseases.


2014 ◽  
Vol 13 (4) ◽  
pp. 10863-10877 ◽  
Author(s):  
H.M. Liu ◽  
N. Rao ◽  
D. Yang ◽  
L. Yang ◽  
Y. Li ◽  
...  

RNA Biology ◽  
2018 ◽  
Vol 15 (9) ◽  
pp. 1215-1227 ◽  
Author(s):  
Sheng-Peng Yu ◽  
Cheng Liang ◽  
Qiu Xiao ◽  
Guang-Hui Li ◽  
Ping-Jian Ding ◽  
...  

2018 ◽  
Vol 23 (2) ◽  
pp. 1427-1438 ◽  
Author(s):  
Sheng-Peng Yu ◽  
Cheng Liang ◽  
Qiu Xiao ◽  
Guang-Hui Li ◽  
Ping-Jian Ding ◽  
...  

2020 ◽  
Vol 7 ◽  
Author(s):  
Xiujuan Lei ◽  
Cheng Zhang ◽  
Yueyue Wang

In recent years, latent metabolite-disease associations have been a significant focus in the biomedical domain. And more and more experimental evidence has been adduced that metabolites correlate with the diagnosis of complex human diseases. Several computational methods have been developed to detect potential metabolite-disease associations. In this article, we propose a novel method based on the spy strategy and an artificial bee colony (ABC) algorithm for metabolite-disease association prediction (SSABCMDA). Due to the fact that there are large parts of missing associations in unconfirmed metabolite-disease pairs, spy strategy is adopted to extract reliable negative samples from unconfirmed pairs. Considering the effects of parameters, the ABC algorithm is utilized to optimize parameters. In relevant cross-validation experiments, our method achieves excellent predictive performance. Moreover, three types of case studies are conducted on three common diseases to demonstrate the validity and utility of SSABCMDA method. Relevant experimental results indicate that our method can predict potential associations between metabolites and diseases effectively.


2019 ◽  
Vol 15 (6) ◽  
pp. 442-450 ◽  
Author(s):  
Guobo Xie ◽  
Zecheng Huang ◽  
Zhenguo Liu ◽  
Zhiyi Lin ◽  
Lei Ma

In recent years, an increasing number of biological experiments and clinical reports have shown that lncRNA is closely related to the development of various complex human diseases.


RSC Advances ◽  
2017 ◽  
Vol 7 (71) ◽  
pp. 44961-44971 ◽  
Author(s):  
Changlong Gu ◽  
Bo Liao ◽  
Xiaoying Li ◽  
Lijun Cai ◽  
Haowen Chen ◽  
...  

According to the miRNA and disease similarity network, the unknown associations are predicted by combining the known miRNA-disease association network based on collaborative filtering recommendation algorithm.


Author(s):  
M.A. Gregory ◽  
G.P. Hadley

The insertion of implanted venous access systems for children undergoing prolonged courses of chemotherapy has become a common procedure in pediatric surgical oncology. While not permanently implanted, the devices are expected to remain functional until cure of the primary disease is assured. Despite careful patient selection and standardised insertion and access techniques, some devices fail. The most commonly encountered problems are colonisation of the device with bacteria and catheter occlusion. Both of these difficulties relate to the development of a biofilm within the port and catheter. The morphology and evolution of biofilms in indwelling vascular catheters is the subject of ongoing investigation. To date, however, such investigations have been confined to the examination of fragments of biofilm scraped or sonicated from sections of catheter. This report describes a novel method for the extraction of intact biofilms from indwelling catheters.15 children with Wilm’s tumour and who had received venous implants were studied. Catheters were removed because of infection (n=6) or electively at the end of chemotherapy.


Sign in / Sign up

Export Citation Format

Share Document